Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cohort Study for Local Stereotactic Body Radiotherapy in Patients With Oligometastatic or Oligoprogressive Cancer

NCT07121335 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT07121335
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07121335 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cohort Study for Local Stereotactic Body Radiotherapy in Patients With Oligometastatic or Oligoprogressive Cancer
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Recruiting
Start date
May 1, 2025
Completion date
March 31, 2030
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ctdna, oligometastasis, oligoprogression, patient-reported outcomes (pro), stereotactic body radiation therapy (sbrt)